Advances in HPV detection by Hybrid Capture®

Papillomavirus Report

Volumn 12, Issue 6, 2001, Pages 145-154

  Lorincz A ^a   Anthony, J ^a  

^a Digene Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTAVIDIN; VIRUS DNA;

ANALYTIC METHOD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOLOGY; CYTOMEGALOVIRUS; DEVICE; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS; INTERMETHOD COMPARISON; NEISSERIA GONORRHOEAE; REVIEW; SAMPLING; VIRUS DETECTION; WART VIRUS;

EID: 0035209017     PISSN: 09574190     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens
2. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: A study of 7932 women
3. Managing atypical squamous cells of undetermined significance in Papanicolaou smears
4. Comparison of three management strategies for patients with Atypical Squamous Cells of Undetermined Significance (ASCUS): Baseline results from a randomised trial
5. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
6. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada
7. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions
8. Prediction of cervical intraepithelial neoplasia 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears
9. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
10. HPV testing in primary screening of older women
11. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results
12. Comparison of PCR- and Hybrid Capture-based HPV detection systems using multiple cervical specimen collection strategies
13. Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant
14. A multicenter study evaluation of the Digene Hybrid Capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards
15. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation
16. Evaluation of the Digene Hybrid Capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens
17. Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens
18. Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the Hybrid Capture II signal amplification probe test
19. Human papillomavirus testing for primary screening of cervical cancer precursors
20. Hybrid Capture®: A system for nucleic acid detection by signal amplification technology
21. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA
22. Use of a Hybrid Capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus
23. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
24. Reliable high risk HPV DNA testing by polymerase chain reaction: An intermethod and intramethod comparison
25. Detection of high-risk HPV types by the Hybrid Capture 2 test
26. Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening
27. Concordance of human papillomavirus in the cervix and urine among inner city adolescents
28. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and Hybrid Capture
29. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction
30. Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high risk human papillomavirus types
31. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types
32. A systematic review of the role of human papillomavirus testing within a cervical screening programme
33. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review
34. Meta-analysis of Pap test accuracy
35. Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness
36. 1,2-dioxetanes: Novel chemiluminescent enzyme substrates. Applications to immunoassays
37. Human papillomavirus genotypes in rural Mozambique